I-N(4)-Hydroxycytidine CAS 3258-02-4 EIDD-1931 Ikhwalithi ephezulu ye-NHC

Incazelo emfushane:

Igama Lekhemikhali: N(4)-Hydroxycytidine

Amazwi afanayo: EIDD-1931 (NHC);I-β-D-N4-Hydroxycytidine

I-CAS: 3258-02-4

Ukubukeka: Impushana Emhlophe ukuya EmhlopheUbumsulwa: ≥98.0%

I-metabolite esebenzayo ye-Molnupiravir (EIDD-2801), i-COVID-19 inhibitor ethembisayo

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

Inquiry: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Nikeza Ngokuhlanzeka Okuphezulu kanye Nekhwalithi Ezinzile
Igama Lekhemikhali: N(4)-Hydroxycytidine;I-EIDD-1931 (NHC)
I-CAS: 3258-02-4
I-metabolite esebenzayo ye-Molnupiravir, i-COVID-19 inhibitor ethembisayo

Chemical Properties:

Igama Lekhemikhali I-N(4)-I-Hydroxycytidine
Omqondofana I-EIDD-1931 (NHC);I-β-D-N4-Hydroxycytidine
Inombolo ye-CAS 3258-02-4
Inombolo yeCAT I-RF-PI309
Isimo Sesitoko Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumakhilogremu
I-Molecular Formula I-C9H13N3O6
Isisindo samangqamuzana 259.22
I-Melting Point 169.0 ~ 172.0℃
Ukuncibilika Incibilika ku-100 mM ku-DMSO naku-50 mM Emanzini
Ukuminyana 1.93±0.1 g/cm3
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka Impushana Emhlophe Kuya Kumhlophe
I-NMR Ihambisana Nesakhiwo
Ukuhlanzeka / Indlela Yokuhlaziya >98% (HPLC)
Ukulahlekelwa Ekumisweni ≤1.0%
Ukungcola Okukodwa ≤0.50%
Izinsimbi Ezisindayo ≤20ppm
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa I-metabolite esebenzayo ye-Molnupiravir (EIDD-2801), i-COVID-19 inhibitor

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, isigubhu seCardboard, 25kg/Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.

Izinzuzo:

1

I-FAQ:

Isicelo:

I-N(4)-Hydroxycytidine (EIDD-1931 , β-d-N4-hydroxycytidine, NHC, CAS 3258-02-4) iyi-metabolite esebenzayo ye-EIDD-2801, i-COVID-19 inhibitor ethembisayo.I-EIDD-1931 (NHC) inomsebenzi obanzi wokulwa namagciwane ngokumelene nama-coronavirus amaningi, okuhlanganisa i-SARS-CoV-2, i-MERS-CoV, i-SARS-CoV, kanye neqembu le-zoonotic elihlobene i-2b noma i-2c Bat-CoVs anesilinganiso se-IC50 sika-0.15 μM, kanye kwandisa amandla ngokumelene ne-coronavirus ephethe ukuguqulwa kokumelana ne-nucleoside analog inhibitor remdesivir.Kumagundane atheleleke nge-SARS-CoV noma i-MERS-CoV, kokubili ukuphathwa kwe-prophylactic kanye nokwelapha kwe-Molnupiravir (EIDD-2801), i-NHC-prodrug etholakala ngomlomo (β-D-N4-hydroxycytidine-5'-isopropyl ester), umsebenzi wamaphaphu othuthukisiwe. , kanye nokunciphisa titer yegciwane kanye nokuncipha kwesisindo somzimba.Ukuncipha kwesivuno se-MERS-CoV ku-vitro kanye ne-vivo kuhlotshaniswa nokwanda kokuguquka kwemvamisa ku-viral kodwa hhayi iseli ye-RNA yokusingatha, okusekela indlela ye-mutagenesis ebulalayo ku-CoV.Amandla e-NHC/EIDD-2801 ngokumelene nama-coronavirus amaningi kanye ne-oral bioavailability agqamisa ukusetshenziswa kwayo okungase kube isinqamuleli esisebenzayo sokulwa ne-SARS-CoV-2 namanye ama-zoonotic coronaviruses esizayo.

Bhala umyalezo wakho lapha futhi usithumelele wona